Send the following on WhatsApp
Continue to ChatFirst Phase 3 TREMFYA (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis https://www.mychesco.com/a/news/regional/first-phase-3-tremfya-guselkumab-data-in-inflammatory-bowel-disease-show-positive-induction-results-among-patients-with-moderately-to-severely-active-ulcerative-colitis/